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Quantitative evaluation
To evaluate the sensibility of the amyloid incubation assay the fluorescence of Cy3-Aβ40 spot arrays was calibrated analyzing three Cy3-labeled amyloid solutions spotted on epoxysilanecoated HESs at different amyloid concentrations. For sample preparation, a proper amount of the lyophilized Cy3-Aβ40 product has been dissolved in a phosphate-buffered saline containing dimethyl sulfoxide (0.01 M phosphate, 0.154 M sodium chloride, pH 7.4, 10 vol % of DMSO).
The PBS was added until the amyloid concentration reached a final value of 1 μM. Diluted amyloid solutions were prepared by adding the PBS to fresh aliquots of the 1μM amyloid solution in order to reach 1:10 and 1:100 dilutions. After preparation amyloid solutions were stored at −80 °C until use.
Three sets of 4 × 4 spot arrays, replicated two-times, have been spotted for each of the amyloid solutions by using a PerkinElmer Piezorray non-contact system. The volume of spotted drops was 333 pL ± 5%. A reference solution, consist of dilution buffer was spotted at the same time to assure a negative control.
Florescence was measured on the spotted HES with a PerkinElmer Scanarray instrument immediately after the amyloid-spotting procedure. Various acquisition conditions were tested in order to get all spots visible although below the detector saturation value ( Figure S4B ). Under sensor saturation conditions (100% power laser and gain) all the amyloid concentrations clearly appear as white spots ( Figure S4A ). In addition, PBS spots are also detected. As discussed in the full paper, this signal derive from secondary luminescence effects due to the salt components. Error bars determined as standard deviation of 16 spots measured intensity.
S5
Study of any interactions between the anchored amyloid and amyloid target
To explore the tendency of full-length amyloid peptides to form molecular aggregates at the HESs surface through amyloid-amyloid molecular interactions, the binding capacity of Aβ40 spots was compared with the binding capacity of the KLVFF amyloid sequence. Cy3-labeled Aβ40 and KLVFF peptides were arrayed on an epoxysilane-coated slide from a 1 μM and 1 mg/mL peptide solution, respectively. Cy3-Aβ40 incubation test has been performed by assaying, at the same time, the KLVFF sequence and amyloid beta peptide, with a 1 μM Cy3-labeled Aβ40 solution and the relative fluorescence was measured on the dried slide before and immediately after the amyloid incubation.
The amyloid incubation is detailed in the Experimental section of the main manuscript. Briefly, after the spotting step, peptide and amyloid spot arrays were anchored in a humid chamber and S7 then BSA-blocked. After N 2 -drying, the BSA-blocked slide was scanned in order to check for peptide and amyloid spots still visible despite the extensive washings involving in the procedure.
Finally, fluorescence measurements have been performed after the amyloid incubation to check for fluorescent spots deriving from the binding interaction with the KLVFF and Cy3-Aβ40 spot arrays.
As shown in Figure S5A , BSA-blocked HESs does not show fluorescence for the KLVFF spot array. This is consistent with the absence of a fluorescent cyanine marker for this peptide. 
